B. Hoppe

发表

Proton therapy in a pediatric patient with stage III Hodgkin lymphoma

Zuofeng Li, S. Flampouri, N. Mendenhall, 2013, Acta oncologica.

Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate‐risk Hodgkin lymphoma treated with chemo‐radiation therapy: FDG‐PET parameter analysis in a subgroup from COG AHOD0031

Steve Y. Cho, J. Leal, K. Kelly, 2021, Pediatric blood & cancer.

Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma

S. Flampouri, W. Slayton, N. Mendenhall, 2017, Advances in radiation oncology.

Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer

Zuofeng Li, W. Mendenhall, S. Flampouri, 2017, Acta oncologica.

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, American journal of clinical oncology.

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials

Zuofeng Li, W. Mendenhall, R. Marcus, 2013, Acta oncologica.

Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines.

R. Mohan, L. Specht, S. Flampouri, 2018, Blood.

Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.

Zuofeng Li, S. Flampouri, N. Mendenhall, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors

Zuofeng Li, S. Flampouri, R. Hoppe, 2019, Acta oncologica.

American College of Radiology Acr Appropriateness Criteria ® Pediatric Hodgkin Lymphoma Expert Panel on Radiation Oncology–lymphoma: Summary of Literature Review

R. Advani, C. Flowers, A. Ng, 2013 .

Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2014, Journal of gastrointestinal oncology.

Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer

C. Hallemeier, A. Mahajan, D. Trifiletti, 2020, Pancreas.

Proton Therapy and Concomitant Capecitabine for Non-Metastatic Unresectable Pancreatic Adenocarcinoma

Zuofeng Li, P. Kelly, S. Sachsman, 2014 .

Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN.

S. McGovern, J. Thariat, J. Habrand, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.

Joe Y. Chang, A. Lomax, C. Simone, 2016, International journal of radiation oncology, biology, physics.

Radiation Therapy Across Pediatric Hodgkin Lymphoma Research Group Protocols: A Report From the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group

L. Constine, K. Dieckmann, S. Terezakis, 2021, International journal of radiation oncology, biology, physics.

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.

D. Cutter, Shinn-Yn Lin, S. Flampouri, 2017, International journal of radiation oncology, biology, physics.

Pediatric Hodgkin Lymphoma, Version 3.2021.

Jeffrey L. Magee, K. Kelly, K. Roberts, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Pediatric Hodgkin Lymphoma

Z. Guss, S. Terezakis, B. Hoppe, 2019 .

Pediatric hodgkin lymphoma: disparities in survival by race

S. Jhawar, B. Hoppe, P. Cole, 2020, Leukemia & lymphoma.

Proton Therapy for Pediatric Hodgkin Lymphoma

Zuofeng Li, S. Flampouri, D. Indelicato, 2016, Pediatric blood & cancer.

Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab.

W. Harmsen, T. Sio, Y. Lou, 2022, Lung cancer.

Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma

C. Hallemeier, J. Ashman, A. Asaithamby, 2021, Journal of hepatocellular carcinoma.

Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute.

Zuofeng Li, W. Mendenhall, S. Flampouri, 2015, International journal of radiation oncology, biology, physics.

Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer

Zuofeng Li, S. Flampouri, C. Morris, 2013, Acta oncologica.

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017

Charles R. Thomas, P. Spellman, P. Okunieff, 2018, Clinical Cancer Research.

Does Bridging Radiation Therapy Affect the Pattern of Failure After CAR T-cell Therapy in Non-Hodgkin Lymphoma?

B. Stish, S. Ansell, M. Hathcock, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma

S. Terezakis, N. Mendenhall, C. Morris, 2021, International journal of particle therapy.

Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma.

L. Constine, R. Hoppe, N. Mendenhall, 2019, International journal of radiation oncology, biology, physics.

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma

Zuofeng Li, S. Flampouri, H. Katzenstein, 2020, International journal of particle therapy.

Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines.

H. Eich, A. Ng, L. Specht, 2020, International journal of radiation oncology, biology, physics.

Comparison of Techniques for Involved-Site Radiation Therapy in Patients with Lower Mediastinal Lymphoma.

Zuofeng Li, S. Flampouri, N. Mendenhall, 2019, Practical radiation oncology.

Pulmonary Toxicity Following Proton Therapy for Thoracic Lymphoma.

S. Flampouri, D. Indelicato, N. Mendenhall, 2017, International journal of radiation oncology, biology, physics.

HODGKIN LYMPHOMA — FAVORABLE PROGNOSIS STAGE I AND II

R. Advani, Sonali M. Smith, C. Flowers, 2016 .

ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma.

R. Advani, Sonali M. Smith, C. Flowers, 2016, Oncology.

ACR appropriateness Criteria® pediatric Hodgkin lymphoma

R. Advani, C. Flowers, A. Ng, 2014, Pediatric blood & cancer.

Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement

Steve Y. Cho, K. Kelly, M. Link, 2017, Pediatric blood & cancer.

Postoperative proton therapy in the management of stage III thymoma.

S. Flampouri, A. Monroe, B. Hoppe, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients.

D. Chi, P. Sabbatini, C. Aghajanian, 2001, Gynecologic oncology.

Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2018, Acta oncologica.

Second tumor risk in children treated with proton therapy

D. Indelicato, C. Morris, R. Rotondo, 2021, Pediatric blood & cancer.

Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy

W. Mendenhall, N. Mendenhall, B. Hoppe, 2014, American journal of clinical oncology.

ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer.

Zuofeng Li, D. Zheng, S. Flampouri, 2019, Practical radiation oncology.

Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective Dose

P. Okunieff, F. Kaye, A. Yeung, 2018, Cancer investigation.

Proton therapy for lung cancer

Zuofeng Li, S. Flampouri, N. Mendenhall, 2012, Thoracic cancer.

Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate Cancer.

W. Mendenhall, N. Mendenhall, C. Morris, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma.

R. Hoppe, B. Hoppe, 2015, International journal of radiation oncology, biology, physics.

Consensus Statement on Proton Therapy for Prostate Cancer

J. Liao, W. Mendenhall, N. Vapiwala, 2021, International journal of particle therapy.

Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, International journal of particle therapy.

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study

Zuofeng Li, S. Flampouri, C. Morris, 2020, International journal of particle therapy.

Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer

W. Mendenhall, N. Mendenhall, B. Hoppe, 2013, American journal of clinical oncology.

Risk of pneumonitis and outcomes after mediastinal proton therapy for relapsed/refractory lymphoma: A PTCOG and PCG collaboration.

A. Maity, T. Yock, J. Plastaras, 2020, International journal of radiation oncology, biology, physics.

Hip fractures and pain following proton therapy for management of prostate cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2013, Acta oncologica.

Optimal Therapy for Early-Stage Hodgkin’s Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy

A. Filippi, B. Hoppe, R. Parikh, 2017, Current Oncology Reports.

Lung Dose Escalation

K. Rosenzweig, B. Hoppe, 2011 .

Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database.

A. Yeung, M. Milano, C. Morris, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy

T. Habermann, W. Harmsen, B. Stish, 2022, Blood cancer journal.

Proton Radiotherapy Following Chemotherapy in the Management of Aggressive Mediastinal non-Hodgkin Lymphomas: A PTCOG Lymphoma Subcommittee Collaboration

A. Maity, J. Plastaras, Michele M. Kim, 2022 .

A phase II trial of escalated dose proton radiotherapy with elective nodal irradiation and concomitant chemotherapy for patients with unresectable, borderline resectable, or medically inoperable pancreatic adenocarcinoma.

C. Morris, B. Hoppe, R. Nichols, 2017 .

Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression.

Zuofeng Li, W. Mendenhall, R. Marcus, 2009, International journal of radiation oncology, biology, physics.

Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship Research.

D. Green, L. Constine, R. Skinner, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy.

K. Olivier, N. Mendenhall, J. Lynch, 2010, International journal of radiation oncology, biology, physics.

Complementation of the Radiosensitive M059J Cell Line

C. Kirchgessner, B. Hoppe, R. Jensen, 2000, Radiation research.

Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.

A. Zelenetz, C. Moskowitz, C. Moskowitz, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A positive approach: advances in proton therapy for the treatment of mediastinal lymphoma

B. Hoppe, R. M. Mailhot Vega, 2020, Expert review of hematology.

Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma

S. Jhawar, B. Hoppe, P. Cole, 2019, JAMA oncology.

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.

Zuofeng Li, S. Flampouri, N. Dang, 2014, International journal of radiation oncology, biology, physics.

Pulmonary Function after Proton Therapy for Hodgkin Lymphoma

N. Mendenhall, B. Hoppe, J. Cury, 2019, International journal of particle therapy.

Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

A. Ng, L. Specht, L. Constine, 2018, International journal of radiation oncology, biology, physics.

Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma

Zuofeng Li, S. Flampouri, N. Mendenhall, 2010, Leukemia & lymphoma.

Proton therapy in the management of non-Hodgkin lymphoma

Zuofeng Li, S. Flampouri, S. Sachsman, 2015, Leukemia & lymphoma.

Hypofractionated proton therapy with concurrent chemotherapy for locally advanced non-small cell lung cancer: A Phase I trial from the University of Florida and Proton Collaborative Group.

C. Simone, Zuofeng Li, S. Flampouri, 2020, International journal of radiation oncology, biology, physics.

Management of Radiation Proctitis

W. Mendenhall, N. Mendenhall, B. Hoppe, 2014, American journal of clinical oncology.

Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience.

H. Tun, M. Alhaj Moustafa, Liuyan Jiang, 2020, Clinical lymphoma, myeloma & leukemia.

Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries

C. Simone, W. Hartsell, C. Vargas, 2019, Acta oncologica.

Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience.

J. Shah, D. Gomez, D. Kraus, 2008, International journal of radiation oncology, biology, physics.

Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations.

M. Aznar, S. Flampouri, J. Plastaras, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcomes in men with large prostates (≥ 60 cm3) treated with definitive proton therapy for prostate cancer

Zuofeng Li, W. Mendenhall, L. Mcgee, 2013, Acta oncologica.

Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.

Zuofeng Li, W. Regine, B. Yi, 2012, International journal of radiation oncology, biology, physics.

Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma

Zuofeng Li, S. Flampouri, W. Slayton, 2015, Leukemia & lymphoma.

When is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?

W. Mendenhall, N. Mendenhall, B. Hoppe, 2013, American journal of clinical oncology.

Pulmonary dose tolerance in hemithorax radiotherapy for Ewing sarcoma of the chest wall: Are we overestimating the risk of radiation pneumonitis?

D. Indelicato, R. Rotondo, B. Hoppe, 2021, Pediatric blood & cancer.

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

Zuofeng Li, W. Mendenhall, R. Marcus, 2013, Acta oncologica.

Testosterone Replacement Therapy in Men with Prostate Cancer after Proton Therapy

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2014 .

Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate Cancer.

W. Mendenhall, N. Mendenhall, C. Morris, 2016, International journal of particle therapy.

Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

B. Stish, H. Tun, Liuyan Jiang, 2021, Advances in radiation oncology.

Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity.

N. Vapiwala, A. Butala, N. Mendenhall, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, International journal of radiation oncology, biology, physics.

Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer

W. Mendenhall, N. Mendenhall, C. Morris, 2021, Acta oncologica.

Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement

W. Mendenhall, N. Mendenhall, C. Morris, 2018, American journal of clinical oncology.

Controversies in proton therapy for prostate cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, Chinese Clinical Oncology.

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.

K. Kelly, D. Hodgson, T. Horton, 2022, The New England journal of medicine.

Comparing Breath Hold and Free Breathing during Intensity-Modulated Radiation Therapy and Proton Therapy in Patients with Mediastinal Hodgkin Lymphoma.

Zuofeng Li, S. Flampouri, N. Mendenhall, 2017, International journal of particle therapy.

Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.

C. Simone, S. Feigenberg, R. Rengan, 2019, Practical radiation oncology.

Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.

Zuofeng Li, Stella Flampouri, Zuofeng Li, 2011, Clinical lung cancer.

Radiation‐induced tumor immunity in patients with non‐small cell lung cancer

P. Okunieff, S. Swarts, Zhen-huan Zhang, 2019, Thoracic cancer.

Impact of Detecting Occult Pathologic Nodal Disease During Resection for Malignant Pleural Mesothelioma.

J. Friedberg, J. Stahl, V. Verma, 2020, Clinical lung cancer.

Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses.

J. Shah, D. Kraus, N. Lee, 2009, Archives of otolaryngology--head & neck surgery.

Hemorrhagic Radiation Cystitis

W. Mendenhall, N. Mendenhall, B. Hoppe, 2015, American journal of clinical oncology.

Proton therapy for prostate cancer.

Zuofeng Li, Zuofeng Li, W. Mendenhall, 2011, Oncology.

ACR Appropriateness Criteria: Localized nodal indolent lymphoma.

R. Advani, C. Flowers, L. Constine, 2013, Oncology.

LOCALIZED NODAL INDOLENT LYMPHOMA

R. Advani, C. Flowers, L. Constine, 2013 .

Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.

Zuofeng Li, Zhong Su, Stella Flampouri, 2012, International journal of radiation oncology, biology, physics.

Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes

Perry B. Johnson, H. Wolfsen, J. Jones, 2022, International journal of particle therapy.

Carbon ion radiation therapy in breast cancer: a new frontier

A. Mahajan, D. Trifiletti, C. Beltran, 2020, Breast Cancer Research and Treatment.

Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?

Kenneth E Rosenzweig, Margie A Hunt, E. Yorke, 2008, International journal of radiation oncology, biology, physics.

ACR appropriateness criteria follow-up of Hodgkin lymphoma.

R. Advani, Sonali M. Smith, C. Flowers, 2014, Journal of the American College of Radiology : JACR.

Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry

G. Laramore, L. Mcgee, O. Cahlon, 2016, Acta oncologica.

The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma

A. Zelenetz, A. Reiner, P. Hamlin, 2009, Bone Marrow Transplantation.

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2021, International journal of particle therapy.

Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: a Multi-institutional Experience of Adult Patients by ILROG.

H. Eich, Y. Natkunam, R. Advani, 2020, Blood.

Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy

S. Flampouri, L. Mcgee, C. Morris, 2019, Acta oncologica.

The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiotherapy Era.

Zuofeng Li, S. Flampouri, R. Hoppe, 2020, Practical radiation oncology.

Sperm preservation and neutron contamination following proton therapy for prostate cancer study

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2017, Acta oncologica.

Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors

J. Stahl, N. Mendenhall, C. Morris, 2019, Advances in radiation oncology.

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim-PET.

T. Habermann, S. Ansell, H. Tun, 2022, Haematologica.

Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer

Zuofeng Li, C. Morris, B. Hoppe, 2020, Acta oncologica.

ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma

R. Advani, Sonali M. Smith, C. Flowers, 2015, American journal of clinical oncology.

Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer

S. Flampouri, N. Mendenhall, C. Morris, 2019, Advances in radiation oncology.

A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study.

Zuofeng Li, S. Flampouri, B. McCook, 2016, International journal of radiation oncology, biology, physics.

Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.

K. Rosenzweig, J. Shah, M. Zelefsky, 2007, International journal of radiation oncology, biology, physics.

Postoperative intensity‐modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: Technique, early outcomes, and toxicity

J. Mechalakos, M. Zelefsky, D. Kraus, 2008, Head & neck.

Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.

J. Shah, M. Zelefsky, D. Gomez, 2008, International journal of radiation oncology, biology, physics.

Survivor and Caregiver Expectations and Preferences Regarding Lung Cancer Treatment.

K. Hitchcock, A. Yeung, N. Mendenhall, 2019, International journal of particle therapy.

Radiotherapy in Early-stage Gastric MALT

N. Mendenhall, C. Morris, B. Hoppe, 2020, American journal of clinical oncology.

Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role?

Y. Zeidan, B. Hoppe, M. Kharfan-Dabaja, 2020, International journal of particle therapy.

Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2019, Cancer investigation.

Utilization of Radiation for Pediatric Hodgkin Lymphoma

B. Hoppe, R. Nanda, A. Charpentier, 2018 .

ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.

R. Advani, Sonali M. Smith, C. Flowers, 2016, American journal of clinical oncology.

Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria

R. Advani, Sonali M. Smith, C. Flowers, 2020, Leukemia & lymphoma.

Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma.

H. Tun, T. Witzig, G. Wiseman, 2022, Clinical lymphoma, myeloma & leukemia.

Radiation Therapy of Cutaneous Lymphoma

N. Mendenhall, B. Hoppe, 2013 .

Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study

L. Court, G. Armstrong, D. Mulrooney, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Follicular Lymphoma: Treatment for Early-Stage, Grades 1 and 2, and Advanced-Stage Disease

B. Hoppe, 2017 .

Proton Therapy in the Management of Lymphoma

S. Flampouri, B. Hoppe, C. Ho, 2014, Cancer journal.

Advancing the Therapeutic Index in Stage III/IV Pediatric Hodgkin Lymphoma with Proton Therapy

Zuofeng Li, S. Flampouri, W. Slayton, 2014 .

Proton therapy for Hodgkin lymphoma

S. Flampouri, B. Hoppe, M. Rutenberg, 2014, Current Hematologic Malignancy Reports.

Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.

Zuofeng Li, S. Flampouri, N. Dang, 2012, International journal of radiation oncology, biology, physics.

Estimating the Number of Patients Eligible for Carbon Ion Radiotherapy in the United States

A. Mahajan, D. Trifiletti, R. Foote, 2020, International journal of particle therapy.

Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees

Joe Y. Chang, Xiaodong Zhang, Steven H. Lin, 2021, Frontiers in Oncology.

Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report

N. Vapiwala, C. Pinnix, J. Plastaras, 2021, Journal of Cancer Education.

Bacterial Urinary Tract Infection after Fiducial Marker Placement or Prostate Biopsy

W. Mendenhall, N. Mendenhall, B. Hoppe, 2014 .

Carbon ion radiotherapy in the management of non‐small cell lung cancer

T. Sio, H. Ishikawa, Y. Lou, 2022, Precision Radiation Oncology.

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma

A. Maity, S. Flampouri, J. Plastaras, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Improving the Therapeutic Ratio by Using Proton Therapy in Patients With Stage I or II Seminoma

Zuofeng Li, D. Indelicato, N. Mendenhall, 2013, American journal of clinical oncology.

What men want: Results from a national survey on decision making for prostate cancer treatment and research participation

N. Mendenhall, C. Morris, B. Hoppe, 2021, Clinical and translational science.

Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy.

Zuofeng Li, S. Flampouri, W. Slayton, 2012, Oncology.

Patient preferences for reducing bowel adverse events following prostate radiotherapy

J. Bridges, E. Janssen, B. Hoppe, 2020, PloS one.

Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity

T. George, N. Mendenhall, H. Asbun, 2013, Acta oncologica.

Cardiac MRI for Detecting Early Cardiac Toxicity after Proton Therapy for Hodgkin Lymphoma.

S. Flampouri, N. Mendenhall, B. Hoppe, 2019, International journal of particle therapy.

Evaluating Cardiac Biomarkers after Chemotherapy and Proton Therapy for Mediastinal Hodgkin Lymphoma.

S. Flampouri, N. Mendenhall, C. Morris, 2017, International journal of particle therapy.

A comparative study of prostate PTV margins for patients using hydrogel spacer or rectal balloon in proton therapy.

W. Mendenhall, N. Mendenhall, B. Hoppe, 2020, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2019, Physics in medicine and biology.

Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results.

Zuofeng Li, S. Flampouri, N. Mendenhall, 2012, Clinical lung cancer.

Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma.

W. Slayton, S. Parsons, N. Mendenhall, 2021, International journal of radiation oncology, biology, physics.

Rationale and early outcomes for the management of thymoma with proton therapy.

S. Flampouri, B. Hoppe, R. Henderson, 2018, Translational lung cancer research.

Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study

K. Kelly, D. Hodgson, Inki Lee, 2023, British journal of haematology.

Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer.

Zuofeng Li, W. Mendenhall, R. Marcus, 2012, International journal of radiation oncology, biology, physics.

Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas.

J. Cerhan, H. Tun, Liuyan Jiang, 2023, Clinical lymphoma, myeloma & leukemia.

Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design

J. Ashman, R. Imai, P. Rose, 2023, Cancers.

RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only).

B. Hoppe, R. Nichols, 2013, Journal of gastrointestinal oncology.

Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).

Steve Y. Cho, K. Kelly, T. Horton, 2022, Journal of Clinical Oncology.

Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, International journal of radiation oncology, biology, physics.

Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or HIFU

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2013 .

Spermatogenesis After Testicular Radiation Exposure in Children: Initial Results from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) Initiative

L. Cohen, I. Naqa, L. Constine, 2019, International Journal of Radiation Oncology, Biology, Physics.

Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton Therapy.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2017, International journal of particle therapy.

Patient-reported Hip Symptoms following Treatment with Proton Therapy for Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2013 .

RECURRENT HODGKIN LYMPHOMA Expert Panel on Radiation Oncology

Leslie, Mendenhall, C. Flowers, 2016 .

Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors

L. Court, D. Followill, Choonsik Lee, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Erratum: Proton therapy for adults with mediastinal lymphomas: The International Lymphoma Radiation Oncology Group guidelines (Blood (2018) 132, 16 (1635-1646) DOI: 10.1182/blood-2018-03-837633)

J. Plastaras, B. Dabaja, B. Hoppe, 2019 .

Genitourinary Cancers Five-Year Biochemical Results , Toxicity , and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2022 .

Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2014, International journal of radiation oncology, biology, physics.

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

H. Sandler, M. Regan, M. Sanda, 2014, Cancer.

Children's Oncology Group's 2023 blueprint for research: Radiation oncology

S. Wolden, C. Hua, A. Paulino, 2023, Pediatric blood & cancer.

Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

G. Armstrong, D. Mulrooney, L. Robison, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Don't put the CART before the horse: The role of radiation therapy in peri-CAR T-cell therapy for aggressive B-cell non-Hodgkin lymphoma.

B. Stish, S. Ansell, M. Hathcock, 2022, International journal of radiation oncology, biology, physics.

Reduction of prostate intrafraction motion using gas-release rectal balloons.

Zuofeng Li, W. Mendenhall, T. Zhao, 2012, Medical physics.

FOLLOW-UP OF HODGKIN LYMPHOMA Expert

L. Constine, A. Younes, Christopher R. Flowers, 2014 .

Radiation for prostate cancer: intensity modulated radiation therapy versus proton beam.

H. Sandler, B. Hoppe, C. Bryant, 2015, The Journal of urology.

(S016) Intermediate-risk prostate cancer: a medicare-based cost comparison of five radiotherapy regimens.

W. Mendenhall, N. Mendenhall, B. Hoppe, 2015, Oncology.

Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma

Shaun Parsons, S. Castellino, B. Hoppe, 2023, Pediatric blood & cancer.

Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma

B. Stish, S. Ansell, M. Hathcock, 2023, Haematologica.

Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group

K. Kelly, S. Kaste, K. McCarten, 2020, Pediatric blood & cancer.

Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer.

L. Ben-Porat, D. Chi, P. Sabbatini, 2004, Gynecologic oncology.

Bi-Institutional Report on Consolidative Proton Therapy after Initial Chemotherapy for Mediastinal Diffuse Large B-Cell and Primary Mediastinal Large B-Cell Lymphomas

A. Maity, S. Flampouri, J. Plastaras, 2018, International Journal of Radiation Oncology*Biology*Physics.

Oral Scientific SessionsRates of Toxicity and Outcomes After Mediastinal Proton Therapy For Relapsed/Refractory Lymphoma

A. Maity, S. Flampouri, J. Plastaras, 2017 .

An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia.

J. Seuntjens, R. Tsang, R. Orecchia, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger

Zuofeng Li, W. Mendenhall, R. Marcus, 2012, Cancer.

Selective nodal irradiation of regionally advanced non‐small‐cell lung cancer with proton therapy and IMRT: A dosimetric comparison

Zuofeng Li, S. Flampouri, N. Mendenhall, 2012, Thoracic cancer.

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration

A. Maity, J. Plastaras, Michele M. Kim, 2022, Advances in Radiation Oncology.

Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

A. Ng, L. Specht, L. Constine, 2018, International journal of radiation oncology, biology, physics.

Primary Mediastinal B cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium SocietyTM Appropriate Use Criteria.

R. Advani, Sonali M. Smith, C. Flowers, 2021, International journal of radiation oncology, biology, physics.

ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.

R. Advani, L. Constine, S. Terezakis, 2016, American journal of clinical oncology.

ACR Appropriateness Criteria s Hodgkin Lymphoma—Unfavorable Clinical Stage I and II

R. Advani, L. Constine, A. Younes, 2016 .

ACR Appropriateness Criteria: Localized nodal indolent lymphoma.

R. Advani, C. Flowers, L. Constine, 2013, Oncology.